These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 9569051)
21. Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer. Setälä L; Lipponen P; Tammi R; Tammi M; Eskelinen M; Alhava E; Kosma VM Histopathology; 2001 Jan; 38(1):13-20. PubMed ID: 11135041 [TBL] [Abstract][Full Text] [Related]
22. [Expression tumor stem cell surface marker CD44 in gastric cancer and its significance]. Xie JW; Huang CM; Zheng CH; Li P; Wang JB; Lin JX; Lu J Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1107-12. PubMed ID: 24277411 [TBL] [Abstract][Full Text] [Related]
23. CD44 variant 6 in endometrioid carcinoma of the uterus: its expression in the adenocarcinoma component is an independent prognostic marker. Hoshimoto K; Yamauchi N; Takazawa Y; Onda T; Taketani Y; Fukayama M Pathol Res Pract; 2003; 199(2):71-7. PubMed ID: 12747468 [TBL] [Abstract][Full Text] [Related]
24. Splice variants of CD44 in human cervical cancer stage IB to IIB. Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of CD44 variants 6 and 7 in human endometrial cancer. Katsura M; Furumoto H; Nishimura M; Kamada M; Aono T Gynecol Oncol; 1998 Nov; 71(2):185-9. PubMed ID: 9826458 [TBL] [Abstract][Full Text] [Related]
26. Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma. Kim HS; Park YB; Oh JH; Jeong J; Kim CJ; Lee SH Clin Orthop Relat Res; 2002 Mar; (396):184-90. PubMed ID: 11859242 [TBL] [Abstract][Full Text] [Related]
27. Up-regulation of CD44 variant exon expression in endometrial carcinomas: analysis of mRNA and protein isoforms, and relation to clinicopathological factors. Saegusa M; Okayasu I Jpn J Cancer Res; 1998 Mar; 89(3):291-8. PubMed ID: 9600123 [TBL] [Abstract][Full Text] [Related]
28. Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas. Afify AM; Ferguson AW; Davila RM; Werness BA Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):309-14. PubMed ID: 11759056 [TBL] [Abstract][Full Text] [Related]
29. The Role of CD44 and RHAMM in Endometrial (Endometrioid Type) Cancer: An Immunohistochemical Study. Klarić M; Haller H; Brnčić Fischer A; Babarović E; Prijić A; Eminović S Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):606-612. PubMed ID: 29734248 [TBL] [Abstract][Full Text] [Related]
30. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma. Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174 [TBL] [Abstract][Full Text] [Related]
31. Alteration of CD44 and cadherins expression: possible association with augmented aggressiveness and invasiveness of endometrial carcinoma. Leblanc M; Poncelet C; Soriano D; Walker-Combrouze F; Madelenat P; Scoazec JY; Darai E Virchows Arch; 2001 Jan; 438(1):78-85. PubMed ID: 11213839 [TBL] [Abstract][Full Text] [Related]
32. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas. Tran TA; Kallakury BV; Sheehan CE; Ross JS Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer. Sliutz G; Tempfer C; Winkler S; Kohlberger P; Reinthaller A; Kainz C Br J Cancer; 1995 Dec; 72(6):1494-7. PubMed ID: 8519665 [TBL] [Abstract][Full Text] [Related]
34. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753 [TBL] [Abstract][Full Text] [Related]
35. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan. Kuo MY; Cheng SJ; Chen HM; Kok SH; Hahn LJ; Chiang CP J Oral Pathol Med; 1998 Oct; 27(9):428-33. PubMed ID: 9790096 [TBL] [Abstract][Full Text] [Related]
36. Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer. Müller W; Schneiders A; Heider KH; Meier S; Hommel G; Gabbert HE J Pathol; 1997 Oct; 183(2):222-7. PubMed ID: 9390037 [TBL] [Abstract][Full Text] [Related]
37. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma. Gotoda T; Matsumura Y; Kondo H; Ono H; Kanamoto A; Kato H; Watanabe H; Tachimori Y; Nakanishi Y; Kakizoe T Gut; 2000 Jan; 46(1):14-9. PubMed ID: 10601048 [TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of CD44v5 expression in human thymic epithelial neoplasms. Lee SC; Harn HJ; Lin TS; Yeh KT; Liu YC; Tsai CS; Cheng YL Ann Thorac Surg; 2003 Jul; 76(1):213-8; discussion 218. PubMed ID: 12842543 [TBL] [Abstract][Full Text] [Related]
39. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer. Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810 [TBL] [Abstract][Full Text] [Related]
40. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. Endo K; Terada T J Hepatol; 2000 Jan; 32(1):78-84. PubMed ID: 10673070 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]